
|Videos|November 22, 2021
Topical oxymetazoline 0.1% and upper lid elevation: An overview with Shane Foster, OD
Author(s)Shane Foster, OD, Brooke Henson, Editor
Topical oxymetazoline HCL ophthalmic solution 0.1% (RVL-1201, RVL Pharmaceuticals, Inc.) provides significant improvement in upper eyelid elevation for ptosis patients
Advertisement
Shane Foster, OD discusses highlights from his American Academy of Optometry poster presentation on upper eyelid elevation in acquired ptosis patients with once-daily topical Oxymetazoline 0.1%.
Newsletter
Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Optometry Times - Clinical News & Expert Optometrist Insights
1
First chronic hypotony clinic established at Moorfields Eye Hospital
2
What’s new in 2025-2026: Ophthalmic drugs and drug delivery systems
3
Euclid Vision Corporation launches new Be Free Day lens for myopia management
4
The top stories in glaucoma to enter the new year with
5












































